Gabriela Ortiz Díaz

Mrs. Gabriela Ortiz Díaz


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
GVGemma Valera
Gemma Valera
MPMaría del Mar Rodríguez San Pedro
María del Mar Rodríguez San Pedro
PCPaula Jara Caro
Paula Jara Caro
VCVíctor Cabanillas
Víctor Cabanillas
GDGabriela Ortiz Díaz
Gabriela Ortiz Díaz
JAJulia Carracedo Añon
Julia Carracedo Añon
Chronic kidney disease (CKD) is associated with a high incidence of cardiovascular disease (CVD) due to the accumulation of uremic toxins, altered redox state, and chronic systemic inflammation. This study aimed to analyze the relationship between the redox status of patients with CKD and the phenotype of microvesicles (MVs) subtypes, and cardiovascular events. The oxidative stress level of each participant was determined using an individualized OXY-SCORE. The relationship between pro-oxidant and antioxidant parameters and the expression of membrane markers in endothelial-derived microvesicles (EMVs) and platelet-derived microvesicles (PMVs) was established. Patients with advanced CKD (ACKD) and hemodialysis (HD) had a higher OXY-SCORE than healthy subjects (HS), whereas peritoneal dialysis (PD) patients had similar scores to HS. PD patients showed elevated PMVs and CD41 expression, whereas HD patients had higher EMVs and CD31 expression. Patients with ACKD had higher tissue factor (TF) expression in the PMVs and EMVs. TF expression was correlated with xanthine oxidase (XO) activity and was negatively correlated with antioxidant parameters. Patients with cardiovascular events show elevated TF. In conclusion, microvesicles and oxidative stress may serve as markers of cardiovascular risk in CKD, with TF expression in PMVs and EMVs being potential predictive and prognostic biomarkers of CVD.

16 October 2025 in Oxygen
Verified
Journal Article
Open access
PDF file
GVGemma Valera
Gemma Valera
PCPaula Jara Caro
Paula Jara Caro
MPMaría del Mar Rodríguez San Pedro
María del Mar Rodríguez San Pedro
CYClaudia Yuste
Claudia Yuste
GDGabriela Ortiz Díaz
Gabriela Ortiz Díaz
EMEnrique Morales
Enrique Morales
Chronic kidney disease is closely associated with an increased risk of cardiovascular disease. Although kidney transplantation represents the treatment of choice for patients with end-stage chronic kidney disease, it is also linked to significant cardiovascular risk. This study aimed to evaluate the relationship between cardiovascular pathology and oxidative status in kidney transplant recipients, while also assessing the influence of disease etiology and humoral immune response on oxidative imbalance. A cross-sectional analysis was conducted in individuals with advanced chronic kidney disease (n = 36) and kidney transplant recipients (n = 40). A total of 18 healthy subjects were included. The enzymatic activities of xanthine oxidase, superoxide dismutase, and glutathione peroxidase, and levels of lipid peroxidation products, oxidized glutathione, and reduced glutathione were measured using spectrophotometry in plasma and mononuclear and polymorphonuclear leukocytes isolated using Ficoll density gradients. Individual oxidative status was evaluated using OXYSCORE. Kidney transplantation was associated with a higher incidence of cardiovascular disease (p < 0.01) and increased levels of both prooxidant (p < 0.01) and antioxidant parameters (p < 0.01). Elevated OXYSCORE values were observed particularly in patients with nephroangiosclerosis, diabetic kidney disease, polycystic kidney disease (p < 0.05), and cardiovascular comorbidities (p < 0.001). Additionally, the presence of anti-graft antibodies correlated with higher oxidative scores. These findings suggest that OXYSCORE may serve as a potential indicator of cardiovascular damage in kidney transplant recipients.

22 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
VGValera-Arévalo Gemma
Valera-Arévalo Gemma
PCPaula Jara Caro
Paula Jara Caro
MPMaría del Mar Rodríguez San Pedro
María del Mar Rodríguez San Pedro
CYClaudia Yuste
Claudia Yuste
GDGabriela Ortiz Díaz
Gabriela Ortiz Díaz
EMEnrique Morales
Enrique Morales
Chronic kidney disease is closely associated with an increased risk of cardiovas-cular disease. Although kidney transplantation represents the treatment of choice for patients with end-stage chronic kidney disease, it is also linked to significant cardio-vascular risk. This study aimed to evaluate the relationship between cardiovascular pathology and oxidative status in kidney transplant recipients, while also assessing the influence of disease etiology and humoral immune response on oxidative imbalance. A cross-sectional analysis was conducted in thirty-six individuals with advanced chronic kidney disease and forty kidney transplant recipients. The enzymatic activities of xan-thine oxidase, superoxide dismutase, and glutathione peroxidase, levels of lipid perox-idation products, oxidized glutathione, and reduced glutathione, were measured by spectrophotometry in plasma and mononuclear and polymorphonuclear leukocytes isolated using Ficoll density gradients. Individual oxidative status was evaluated using an OXYSCORE. Kidney transplantation was associated with a higher incidence of car-diovascular disease and increased levels of both pro-oxidant and antioxidant bi-omarkers. Elevated OXYSCORE values were observed particularly in patients with nephroangiosclerosis, diabetic kidney disease, polycystic kidney disease, and cardio-vascular comorbidities. Additionally, the presence of anti-graft antibodies correlated with higher oxidative scores. These findings suggest that redox status may serve as a potential biomarker for cardiovascular risk in kidney transplant recipients.